3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 4
1
Status
Completed
9
Unknown
2
Terminated
2
Recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Conditions
Pain
2
Neoplasm Metastasis
2
Triple Negative Breast Neoplasms
1
Trigger Finger Disorder
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Mesothelioma
1
Median Neuropathy
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, B-Cell
1
Lung Neoplasms
1
Leukemia
1
Head and Neck Neoplasms
1
Ganglion Cysts
1
Emergence Delirium
1
Delirium
1
De Quervain Disease
1
Carcinoma
1
Burkitt Lymphoma
1
Interventions
Morphine
7
Fentanyl
5
Radiotherapy
4
Methadone
4
Zoledronic Acid
3
Tapentadol
2
Ropivacaine
2
Pregabalin
2
Prednisone
2
Ketamine
2
Ibandronic Acid
2
Hydromorphone
2
Glutamine
2
Cryotherapy
2
Cryosurgery
2
Bupivacaine
2
Acupuncture Therapy
2
Acetaminophen
2
pegfilgrastim
1
oxycodone naloxone combination
1
naloxegol
1
ixabepilone
1
incobotulinumtoxinA
1
imisopasem manganese
1
cyclobenzaprine
1
cabozantinib
1
acetaminophen, aspirin, caffeine drug combination
1
Zolpidem
1
Surveys and Questionnaires
1
Sugars
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Terminated
×
Pain
×
Acetaminophen
×
Clear all
NCT05088876
2026-04-13
ParOP
Insel Gruppe AG, University Hospital Bern
Phase 4
Terminated
7 enrolled
NCT02706769
2019-09-27
PaSO
University of Edinburgh
Phase NA
Terminated
34 enrolled